Dr. MiltieAtlas by Dr. Miltie™Nationwide Grant Intelligence
Open — 2027 Mathilde Krim Fellowship LOI stage through November 12, 2026, 3 p.m. Eastern; invitation-only full applications due January 11, 2027.

International — amfAR 2027 Mathilde Krim Fellowships in Biomedical HIV Research (Up to $180,000 + $50,000)

amfAR 2027 Mathilde Krim institutional biomedical HIV research fellowships: up to $180,000 over two years, plus conditional $50,000 independent-position phase. LOI due November 12, 2026 at 3 p.m. Eastern.

FundingPhase 1: up to $180,000 TOTAL for April 1, 2027–March 31, 2029 (two years), including up to 10% indirect costs. Conditional Phase 2: up to $50,000 additional for one year at independent nonprofit research institution, including up to 10% indirect. $230,000 combined potential NOT a guaranteed individual award. Universal cash match not published; institutional career-development support expected.
DeadlineLetter of Intent: November 12, 2026, 3 p.m. Eastern Time. Invited full application: January 11, 2027, 3 p.m. Eastern Time.
Last verified2026-10-26
Required next actionRead amfAR current 2027 Mathilde Krim RFP and FAQs; verify candidate doctorate eligibility (normally October 2020–October 2023) and institutional nonprofit status, same-institution qualified mentor, distinct biomedical HIV research plan and at least 50% research effort. Submit LOI through amfAR Grants Portal by November 12, 2026 3 p.m. ET with required mentor support; if invited submit institutional budget, approvals and full proposal by January 11, 2027 3 p.m. ET.

Broad Eligibility

Nonprofit biomedical research institutions anywhere worldwide with affiliated eligible postdoctoral researcher and same-institution experienced mentor; degree generally completed Oct 2020–Oct 2023 (exceptions possible). Biomedical HIV prevention/treatment/cure, distinct from mentor; researcher at least 50% effort; institutional grant, not individual payee. Excludes epidemiology, behavioral/social science, health-services, policy and implementation studies.

Atlas Analysis

Official amfAR 2027 Mathilde Krim RFP and current FAQs reviewed 2026-10-26. Grant awarded to nonprofit research institution anywhere globally (FAQ explicit), with qualified postdoctoral fellow; Phase1 TOTAL up to $180k over two years, Phase2 conditional additional $50k one year, both INCLUDING up to 10% indirect, no universal required match. Eligible doctorate Oct2020–Oct2023 except documented exceptions, same-institution mentor, at least 50% fellow effort. Nov12 3pm ET LOI; Jan11 3pm ET invite-only full. FAQs say mentor letter LOI mandatory; institutional signature and budget at invited full. Current funder source https://www.amfar.org/our-work/research/mathilde-krim-fellowships-in-biomedical-research-82/ FAQ https://www.amfar.org/our-work/research/mathilde-krim-fellowships-in-biomedical-research-faq/

Open 2027 competition: Letter of Intent due November 12, 2026, at 3 p.m. Eastern Time. amfAR’s Mathilde Krim Fellowships in Biomedical Research provide research grant funding to eligible nonprofit research institutions to support an exceptional postdoctoral fellow’s transition toward an independent career in biomedical HIV/AIDS research. Although eligibility is evaluated at the investigator level, amfAR awards the grant to the research institution; it is not a standalone stipend paid directly to an individual.

Individual institutional award: Phase 1 provides up to $180,000 total over two years, including up to 10% indirect costs, for projects beginning April 1, 2027 and ending March 31, 2029. A fellow who secures an independent research position at an eligible nonprofit institution may qualify for a separate, conditional Phase 2 award of up to $50,000, including up to 10% indirect costs, for a one-year period. Phase 2 may start during Phase 1 or no later than September 30, 2029. The combined possible award is not guaranteed; Phase 2 is subject to its own eligibility and later approval. A universal cash matching percentage is not published; the host institution must support the fellow’s training and career development.

Applicant eligibility: early-career researchers affiliated with nonprofit research institutions anywhere in the world. The candidate typically must hold a research or clinical doctorate completed between October 2020 and October 2023, subject to the funder’s rules on leave, service-related extensions or documented exceptions. The researcher must have a record of impactful peer-reviewed publication and research presentations, be positioned to secure independence by September 2029 and have an experienced eligible mentor at the same institution. At least 50% time and effort must be committed to the fellowship project; the proposed line of work must be independently distinguishable from the mentor’s research.

Research scope: biomedical investigation relevant to HIV prevention, treatment or cure. The current RFP expressly excludes epidemiological, behavioral or social-science, health-services, policy, and implementation-science studies. The award is aimed at individual investigator career development within eligible institutions rather than institutional general operating support. Researchers should not seek overlapping project-specific support from other fellowships or grants.

Two-stage application: submit the initial Letter of Intent in the amfAR Grants Portal by November 12, 2026, at 3 p.m. ET. Include the proposal, candidate career credentials, mentor information and required mentor letter of support. Budgets and reference letters are not requested at LOI stage; invited applicants provide the full application with the institutional signature, detailed budget and justification by January 11, 2027, at 3 p.m. ET. The funder anticipates sending invitations November 30, 2026. An informational webinar is scheduled October 29, 2026 at 3 p.m. ET.

Controlling sources verified October 26, 2026: amfAR 2027 Mathilde Krim Fellowship RFP and submission details and current applicant FAQs. The 2026–27 page specifies 10% indirect cost allowance, unlike an older closed cycle’s different terms. Applicants should verify all institutional eligibility, permitted budget lines, required supporting documents and final portal submission confirmation with amfAR. This is an institutional research grant, not a vendor procurement contract.

Source verificationReferenced source · www.amfar.orgAtlas last verified this record 2026-10-26. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗